✦ LIBER ✦

Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim

✍ Scribed by Covert, W. M.; Murillo, J. R.; Cox, J. E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Pegfilgrastim in

✍ Jeffrey Crawford 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

The safety and efficacy of day 1 versus

✍ Jenny M. Whitworth; Kellie S. Matthews; Kimberly A. Shipman; T. Michael Numnum; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Comparative Safety of Filgrastim versus

✍ Mr. Gary Milkovich; Dr. Ronald J. Moleski; Dr. John F. Reitan; Dr. David M. Dunn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Economic Analysis of Prophylactic Pegfil

✍ Adi Eldar-Lissai; Leon E. Cosler; Eva Culakova; Gary H. Lyman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

382 Efficacy, Safety Profiles and Cost-e

✍ L. Rossi; G. Lo Russo; A. Papa; F. Zoratto; R. Marzano; E. Basso; E. Giordani; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A randomized double-blind multicenter ph

✍ Green, M. D. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 127 KB